ASSESSING THE BEHAVIORAL-EFFECTS AND ABUSE POTENTIAL OF PROPOFOL BOLUS INJECTIONS IN HEALTHY-VOLUNTEERS

被引:40
作者
ZACNY, JP
LICHTOR, JL
ZARAGOZA, JG
COALSON, DW
UITVLUGT, AM
FLEMMING, DC
BINSTOCK, WB
CUTTER, T
APFELBAUM, JL
机构
[1] Department of Anesthesia and Critical Care, Department of Psychiatry, University of Chicago Pritzker School of Medicine, Chicago, IL 60637
关键词
PROPOFOL; GENERAL ANESTHETIC; MOOD; SUBJECTIVE EFFECTS; MEMORY; PSYCHOMOTOR PERFORMANCE; ABUSE LIABILITY;
D O I
10.1016/0376-8716(93)90021-H
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Propofol is a recently introduced intravenous anesthetic agent, commonly administered to surgical patients because it induces anesthesia smoothly (i.e., provides loss of consciousness rapidly and usually with no complications) and is associated with rapid recovery. Propofol has psychoactive effects that could be construed as pleasant, although little abuse liability testing has been done on this agent in humans. Accordingly, we examined various effects of this agent at different subanesthetic doses (0.2 - 0.6 mg/kg) in order to characterize this drug's abuse potential (for recreational use or potential for diversion). Using a double-blind, randomized, crossover design, healthy normal volunteers (N = 10) were injected intravenously with the drug or with placebo. Before the injection and for up to 1 h afterwards, mood (including drug liking), memory and psychomotor performance were assessed. Propofol impaired memory and psychomotor performance and produced changes in 10 of 20 VAS mood ratings. Although there was variability in self-reported drug liking, some subjects clearly liked the effects of propofol, especially at the two higher doses. At the debriefing interview held after completion of the study, five subjects said if they had to participate in one more session in which they were given a choice between being injected with the highest dose (0.6 mg/kg) or a placebo, they would choose propofol. These preliminary results suggest that this agent may have some potential for abuse/diversion and perhaps stricter accountability procedures should be established for this drug in settings where general anesthesia or conscious sedation procedures are done.
引用
收藏
页码:45 / 57
页数:13
相关论文
共 39 条
[1]  
BRICKER SRW, 1988, ANAESTHESIA, V43, P171
[2]  
BROOKE D, 1991, BRIT J ADDICT, V86, P1011
[4]   THE GENERAL ANESTHETIC PROPOFOL ENHANCES THE FUNCTION OF GAMMA-AMINOBUTYRIC ACID-COUPLED CHLORIDE CHANNEL IN THE RAT CEREBRAL-CORTEX [J].
CONCAS, A ;
SANTORO, G ;
MASCIA, MP ;
SERRA, M ;
SANNA, E ;
BIGGIO, G .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (06) :2135-2138
[5]  
Conrad B, 1990, Anasth Intensivther Notfallmed, V25, P186, DOI 10.1055/s-2007-1001046
[6]  
DEGROOD PMRM, 1987, ACTA ANAESTH SCAND, V31, P219
[7]  
DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13
[8]   REINFORCING AND SUBJECTIVE EFFECTS OF DIAZEPAM IN NON-DRUG-ABUSING VOLUNTEERS [J].
DEWIT, H ;
PIERRI, J ;
JOHANSON, CE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 33 (01) :205-213
[9]   INDIVIDUAL-DIFFERENCES IN THE REINFORCING AND SUBJECTIVE EFFECTS OF AMPHETAMINE AND DIAZEPAM [J].
DEWIT, H ;
UHLENHUTH, EH ;
JOHANSON, CE .
DRUG AND ALCOHOL DEPENDENCE, 1986, 16 (04) :341-360
[10]   TESTING THE ABUSE LIABILITY OF ANXIOLYTIC AND HYPNOTIC DRUGS IN HUMANS [J].
DEWIT, H ;
GRIFFITHS, RR .
DRUG AND ALCOHOL DEPENDENCE, 1991, 28 (01) :83-111